These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 17418916)
1. Synthesis and antileishmanial activity of 6-mono-substituted and 3,6-di-substituted acridines obtained by acylation of proflavine. Di Giorgio C; Shimi K; Boyer G; Delmas F; Galy JP Eur J Med Chem; 2007 Oct; 42(10):1277-84. PubMed ID: 17418916 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antileishmanial activities of 4,5-di-substituted acridines as compared to their 4-mono-substituted homologues. Carole DG; Michel DM; Julien C; Florence D; Anna N; Séverine J; Gérard D; Pierre TD; Jean-Pierre G Bioorg Med Chem; 2005 Oct; 13(19):5560-8. PubMed ID: 16081295 [TBL] [Abstract][Full Text] [Related]
3. Photo-inducible cytotoxic and clastogenic activities of 3,6-di-substituted acridines obtained by acylation of proflavine. Benchabane Y; Di Giorgio C; Boyer G; Sabatier AS; Allegro D; Peyrot V; De Méo M Eur J Med Chem; 2009 Jun; 44(6):2459-67. PubMed ID: 19217190 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives. Delmas F; Avellaneda A; Di Giorgio C; Robin M; De Clercq E; Timon-David P; Galy JP Eur J Med Chem; 2004 Aug; 39(8):685-90. PubMed ID: 15276301 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids. Papanastasiou I; Prousis KC; Georgikopoulou K; Pavlidis T; Scoulica E; Kolocouris N; Calogeropoulou T Bioorg Med Chem Lett; 2010 Sep; 20(18):5484-7. PubMed ID: 20719503 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents. Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Agarwal KC; Sharma V; Shakya N; Gupta S Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives. Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121 [TBL] [Abstract][Full Text] [Related]
11. Preparation and antileishmanial activity of lipophilic N-alkyl diamines. da Costa CF; Coimbra ES; Braga FG; dos Reis RC; da Silva AD; de Almeida MV Biomed Pharmacother; 2009 Jan; 63(1):40-2. PubMed ID: 18262385 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiparasitic activity of new 1-nitro, 1-amino and 1-acetamido 9-acridinones. Ngadi L; Bsiri NG; Mahamoud A; Galy AM; Galy JP; Soyfer JC; Barbe J; Placidi M; Rodriguez-Santiago JI; Mesa-Valle C Arzneimittelforschung; 1993 Apr; 43(4):480-3. PubMed ID: 8098606 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines. Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903 [TBL] [Abstract][Full Text] [Related]
14. Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity. Scala A; Cordaro M; Grassi G; Piperno A; Barberi G; Cascio A; Risitano F Bioorg Med Chem; 2014 Feb; 22(3):1063-9. PubMed ID: 24433962 [TBL] [Abstract][Full Text] [Related]
15. 3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids. Kapou A; Benetis NP; Avlonitis N; Calogeropoulou T; Koufaki M; Scoulica E; Nikolaropoulos SS; Mavromoustakos T Bioorg Med Chem; 2007 Feb; 15(3):1252-65. PubMed ID: 17158053 [TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants. Lamidi M; DiGiorgio C; Delmas F; Favel A; Eyele Mve-Mba C; Rondi ML; Ollivier E; Nze-Ekekang L; Balansard G J Ethnopharmacol; 2005 Nov; 102(2):185-90. PubMed ID: 16046090 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas. Kozurková M; Sabolová D; Janovec L; Mikes J; Koval' J; Ungvarský J; Stefanisinová M; Fedorocko P; Kristian P; Imrich J Bioorg Med Chem; 2008 Apr; 16(7):3976-84. PubMed ID: 18258438 [TBL] [Abstract][Full Text] [Related]
18. In vitro activities of 7-substituted 9-chloro and 9-amino-2-methoxyacridines and their bis- and tetra-acridine complexes against Leishmania infantum. Di Giorgio C; Delmas F; Filloux N; Robin M; Seferian L; Azas N; Gasquet M; Costa M; Timon-David P; Galy JP Antimicrob Agents Chemother; 2003 Jan; 47(1):174-80. PubMed ID: 12499188 [TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity of quinovic acid glycosides and cadambine acid isolated from Nauclea diderrichii. Di Giorgio C; Lamidi M; Delmas F; Balansard G; Ollivier E Planta Med; 2006 Dec; 72(15):1396-402. PubMed ID: 17089325 [TBL] [Abstract][Full Text] [Related]